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Abstract
Background: Cerebral ischemia is a devastating condition in which the outcome is heavily influenced by
inflammatory processes, which can augment primary injury caused by reduced blood supply. The cytokines
interleukin-1a (IL-1a) and IL-1b are key contributors to ischemic brain injury. However, there is very little evidence
that IL-1 expression occurs at the protein level early enough (within hours) to influence brain damage after stroke.
In order to determine this we investigated the temporal and spatial profiles of IL-1a and IL-1b expression after
cerebral ischemia.
Findings: We report here that in mice, as early as 4 h after reperfusion following ischemia induced by occlusion of
the middle cerebral artery, IL-1a, but not IL-1b, is expressed by microglia-like cells in the ischemic hemisphere,
which parallels an upregulation of IL-1a mRNA. 24 h after ischemia IL-1a expression is closely associated with areas
of focal blood brain barrier breakdown and neuronal death, mostly near the penumbra surrounding the infarct.
The sub-cellular distribution of IL-1a in injured areas is not uniform suggesting that it is regulated.
Conclusions: The early expression of IL-1a in areas of focal neuronal injury suggests that it is the major form of IL-
1 contributing to inflammation early after cerebral ischemia. This adds to the growing body of evidence that IL-1a
is a key mediator of the sterile inflammatory response.
Findings
Inflammation is recognised as a major contributor to the
worsening of acute brain injury [1]. In particular two pro-
inflammatory members of the IL-1 family of cytokines, IL-
1a and IL-1b, are considered the major effectors of injury,
and inhibiting their signalling with the IL-1 receptor
antagonist (IL-1Ra) is protective in experimental models
of stroke [1], and has shown promise as a treatment in
clinical trials [2]. Mice in which both IL-1a and IL-1b
have been deleted (IL-1a/b double KO) have markedly
reduced damage in response to experimental stroke
caused by middle cerebral artery occlusion (MCAo) [3].
However, the relative contribution of each cytokine to the
evolution of the infarct is not clear since IL-1Ra inhibits
both cytokines. The neuroprotective effects of IL-1Ra are
reduced when administration is delayed beyond 3 h [4],
suggesting that IL-1 expressed early after the insult is
important. IL-1b mRNA is detected within 3-6 h after cer-
ebral ischemia [5,6], although there is very little direct evi-
dence that IL-1b protein is produced, and almost no
information is available about IL-1a. In this study we
sought to determine the spatial distribution of IL-1a and
IL-1b in the mouse brain early (4 h) and late (24 h) after
stroke induced by MCAo. Such a study was required since
strategies aimed at inhibiting inflammation in the brain
will be dictated by the nature of the inflammatory media-
tors produced.
We first investigated whether IL-1 expression could be
detected early (4 h after reperfusion) after ischemic brain
injury, when little neuronal death is present compared to
the 24 h reperfusion time. C57BL6/H mice (male, 12-16
weeks) were subjected to 60 min MCAo and 4 h reperfu-
sion following which they were transcardially perfused
with saline followed by 4% paraformaldehyde. After cryo-
protection brains were cut on a sledge microtome at a
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solution until use. Immunoflourescence on these sections
showed IL-1a expression (AF-400-NA, R & D Systems,
0.4 μg/mL) in microglia in the ipsilateral hemisphere as
identified by co-staining for the microglial marker Iba-1
(019-19741, Wako, 1 μg/mL) (Figure 1A, B). At this time
no IL-1b expression (AF-401-NA, R & D Systems, 0.4
μg/mL) was observed in these areas, with only a few non-
microglial IL-1b-positive cells observed in the capsula
interna, away from the core of the infarct, as reported
previously [7]. No IL-1 expression was observed in the
contralateral hemisphere, confirming that its expression
was a result of the injury (Figure 1A). To further confirm
early IL-1a expression after MCAo, we performed
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Figure 1 Early microglial IL-1a expression after MCAo. Images are of coronal sections from the brains of C57BL6/H mice subjected to 60
min MCAo followed by 4 h reperfusion. Widefield images (A) show IL-1a-expressing (red), Iba1 positive (green) microglia 4 h post-MCAo in the
ipsilateral (Ai) but not the contralateral (ii) hemisphere. Confocal image shows the colocalization of IL-1a and Iba-1 stains in an activated
microglia in the ipsilateral hemisphere (amygdala is shown) (B). No IL-1b-positive (red)/Iba-1 positive (green) microglia were detected in the
ipsilateral amygdala at this time point (Ci, widefield). IL-1b positive, Iba-1 negative cells were detected in the capsula interna (Cii, widefield). IL-1a
and b expressing microglia (IL-1/Iba1 positive cells) were counted (D) in the cortex (CTX), amygdala (AMG), striatum (STR), thalamus (TH) and
hypothalamus (HPT). n = 3 C57BL6/H mice. The average distribution of IL-1a-positive microglia (orange symbols) and a few IL-1b expressing
non-microglial cells (black symbols) are shown at 4 h reperfusion in the ipsilateral hemisphere (E), when histologically little ischemic damage is
detected. Yellow shading indicates areas which typically become ischemic by 24 h reperfusion, while ischemic damage is occasionally observed
in the thalamus and hippocampus (blue shading) at the same time point. Quantitative real-time PCR demonstrated a significant increase of IL-1a
mRNA in tissue homogenates of the ipsilateral hemisphere compared to the contralateral side (F). **P < 0.01, unpaired t test.
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Figure 2 IL-1a is expressed by microglia localized to focal neuronal and BBB injury 24 h after MCAo. Images are coronal sections from
brains of C57BL6/H and CX3CR1-GFP +/- mice 60 min MCAo and 24 h reperfusion. Widefield images show IL-1a-expressing (red), GFP positive
(green) microglia in ipsilateral (Ai), not contralateral (ii) amygdala 24 h after MCAo in a CX3CR1-GFP +/- mouse. IL-1a immunohistochemistry
with cresyl violet co-staining localises IL-1a expressing microglia to the peri-infarct zone in thalamus (Bi) and cortex (Bii) of a C57BL6/H mouse.
Focal IgG staining (red) co-localized with IL-1a positive microglia (green) in the ipsilateral cortex of a C57BL6/H mouse (Ci). No IgG or IL-1a
staining detected in the contralateral cortex (Cii). IL-1a positive microglia detected in larger areas of IgG staining in the ipsilateral (Ciii), but not
contralateral (Civ) hemisphere. Co-localization of IL-1a positive microglia (red) with areas of neuronal loss (blue) in a C57BL6/H mouse (D).
Occasional IL-1a positive microglia also found in areas where neurons were morphologically intact (D, inset). Confocal images (E) are maximum
Z projections (Ei, iii) and confocal slices at the level of the nucleus (Eii, iv) of IL-1a expressing, GFP positive microglia in a CX3CR1-GFP +/-
mouse. Cells with (Ei, ii), and without (Eiii, iv) nuclear IL-1a. Nuclear fluorescence intensities for IL-1a and GFP were quantified from confocal
images, and the fold enrichment of IL-1a and GFP in microglial nuclei was calculated in comparison to whole cell fluorescence (F). All images
are representative of n ≥ 3 mice. Quantification is of n = 4 CX3CR1-GFP +/- mouse brains, with each data point representing an individual cell, n
≥ 30 cells per brain.
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Page 3 of 5quantitative real-time PCR on tissue homogenates of the
ipsilateral and contralateral hemispheres 4 h after reper-
fusion. A significant increase (P < 0.01) was observed in
IL-1a expression, whereas we were unable to detect IL-
1b expression at this time point (Figure 1F).
Only microglia of CX3CR1-GFP+/- mice (as used pre-
viously [7]) express GFP in the brain [8]. CX3CR1-GFP
+/- mice were subjected to 60 min MCAo followed by
24 h reperfusion, when the evolution of the infarct is
advanced and there is substantial neuronal death. Rami-
fied, GFP-positive microglia-like cells in the ipsilateral
hemisphere expressed IL-1a (Figure 2A). IL-1a-positive
microglia were present in the cerebral cortex, the piri-
form cortex, the ventral striatum and the thalamus.
Immunohistochemistry for IL-1a, with cresyl violet co-
staining, localized IL-1a expressing microglia mainly to
the penumbral tissue surrounding the infarct (Figure
2B). IgG cannot cross an intact blood brain barrier
(BBB) and its presence in the brain parenchyma indi-
cates BBB disruption and injury [9]. Staining of coronal
brain sections from C57BL6/H mice (Figure 2C) and
C X 3 C R 1 - G F P + / -m i c e( n o ts h o w n )2 4ha f t e rM C A o
for IL-1a and IgG (BA-2000, Vector Labs, biotinylated
horse anti-mouse IgG, 2 μg/mL; S-32356, Invitrogen,
Alexa 594 conjugated streptavidin, 5 μg/mL) revealed
that IL-1a expressing cells co-localized to areas of focal
BBB damage, mainly near the penumbral regions of the
ipsilateral hemisphere (Figure 2C). The localization of
IL-1a expressing cells with injured brain tissue is also
shown by the co-localization of IL-1a positive microglia
(red) with areas of focal neuronal loss within the com-
promised tissue (absence of NeuN (MAB377, Millipore,
mouse anti-NeuN 5 ug/mL)) (Figure 2D). IL-1a expres-
sing microglia increased overall after 24 h reperfusion
compared to the 4 h time point (two-way ANOVA, P <
0.05, not shown) although the increase was not signifi-
cant when comparing any particular brain regions. At
24 h IL-1b is expressed [7]. Thus the expression of IL-
1a in microglia occurs early after an ischemic insult and
is localized to areas of injury, mostly near peri-infarct
regions.
IL-1a can be actively localized to cell nuclei [10] and
in microglia this may represent a mechanism of inhibit-
ing IL-1a release after hypoxic cellular injury [11]. 24 h
after 60 min MCAo in CX3CR1-GFP +/- mice, micro-
glia expressing GFP also expressed IL-1a that was loca-
lized to the nucleus in some cells (Figure 2Ei, ii), but
not in others (Figure 2Eiii, iv). Confocal images (Leica
TCS SP5 AOBS confocal microscope) were captured
from these sections and were processed and analysed
with Image J http://rsb.info.nih.gov/ij. Regions of interest
for quantification of mean fluorescence intensities
(MFIs) in whole microglia and microglial nuclei were
selected using the GFP and DAPI signals respectively.
MFIs were quantified for IL-1a and GFP in whole
microglia using a maximum Z projection of the confocal
image stack. Nuclear IL-1a and GFP MFIs were quanti-
fied in a confocal slice at the level of the nucleus. The
fold enrichment of IL-1a and GFP in the nucleus were
calculated as follows: Fold enrichment = MFI (nucleus)/
MFI (whole cell). The fold enrichment data suggest that
GFP was uniformly distributed throughout the cell
(Figure 2F). However the spread of IL-1a enrichment
throughout a cell was much broader suggesting that its
localization between the nucleus and cytosol was regu-
lated (Figure 2F). We have previously reported that
IL-1a is retained in the nuclei of dead and dying cells
[11], and also that microglia die in the infarct following
MCAo [12]. Thus it is possible that microglia in an
ischemic brain undergoing cell death processes may
localize IL-1a to the nucleus to limit its release.
These data show that IL-1a is expressed by microglia
at sites of brain injury within a relevant window of time
at which blocking the effects of IL-1 are known to be
neuroprotective [4]. At these times, IL-1b is not present
suggesting that IL-1a is the active IL-1 isoform in med-
iating the early inflammatory period following ischemic
brain injury. This is consistent with recent discoveries
highlighting the earlier appearance of IL-1a in sterile
inflammatory responses, with a later contribution from
IL-1b [13], although functional evidence for a role of
microglia-derived IL-1a in brain injury is not provided
here. In cerebral ischemia the primary injury to brain
cells is caused by the lack of blood supply and so can be
considered sterile. Sterile inflammation is known as a
major contributor to disease and injury [14], and IL-1a
has become recognised as a major mediator of sterile
tissue injury [15,16]. Thus the data presented here
extend our, and others, previous work showing that
IL-1a is a key inflammatory cytokine following tissue
injury. This study also extends our previous in vitro stu-
dies showing that the sub-cellular distribution of IL-1a
is regulated under conditions of hypoxia, which may be
relevant to the regulation of its release and sterile
inflammatory responses [11].
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